1. Home
  2. BCC vs NUVB Comparison

BCC vs NUVB Comparison

Compare BCC & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCC

Boise Cascade L.L.C.

HOLD

Current Price

$85.61

Market Cap

2.6B

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$5.89

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCC
NUVB
Founded
2004
2018
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
BCC
NUVB
Price
$85.61
$5.89
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
9
Target Price
$101.83
$10.44
AVG Volume (30 Days)
388.5K
6.3M
Earning Date
02-19-2026
03-05-2026
Dividend Yield
1.02%
N/A
EPS Growth
N/A
N/A
EPS
5.07
N/A
Revenue
$6,511,894,000.00
$26,748,000.00
Revenue This Year
N/A
$616.63
Revenue Next Year
$3.73
$202.59
P/E Ratio
$17.02
N/A
Revenue Growth
N/A
1137.19
52 Week Low
$65.14
$1.54
52 Week High
$131.27
$9.75

Technical Indicators

Market Signals
Indicator
BCC
NUVB
Relative Strength Index (RSI) 69.40 27.65
Support Level $72.86 $6.07
Resistance Level $87.16 $6.63
Average True Range (ATR) 2.95 0.53
MACD 1.06 -0.42
Stochastic Oscillator 89.24 1.79

Price Performance

Historical Comparison
BCC
NUVB

About BCC Boise Cascade L.L.C.

Boise Cascade Co is a producer of engineered wood products (EWP) and plywood. The firm operates in two reportable segments, namely Wood Products and Building Materials Distribution. The Wood Products segment manufactures laminated veneer lumber (LVL), I-joists, and laminated beams. In addition, it manufactures structural, appearance, and industrial-grade plywood panels, and ponderosa pine lumber. The Building Materials Distribution segment is engaged in the distribution of various building materials, including oriented strand board (OSB), plywood, and lumber; general line items such as siding, composite decking, doors and millwork, metal products, roofing, and insulation; and EWP, among others. The company generates a majority of its revenue from the Building Material Distribution segment.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: